Inflammation-mediated changes in haemostatic variables of pulmonary tuberculosis patients during treatment.

[1]  J. Friedland,et al.  Platelet Activation and the Immune Response to Tuberculosis , 2021, Frontiers in Immunology.

[2]  R. Gilman,et al.  Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis , 2018, American journal of respiratory and critical care medicine.

[3]  P. D. de Groot,et al.  Platelet-monocyte interaction in Mycobacterium tuberculosis infection. , 2018, Tuberculosis.

[4]  M. Hajilooi,et al.  Comparison of L‐selectin blood level and gene polymorphism in tuberculosis patients with healthy individuals , 2018, Journal of clinical laboratory analysis.

[5]  C. Gleissner,et al.  CXCL4-induced macrophages in human atherosclerosis. , 2017, Cytokine.

[6]  Fang-yu Wang,et al.  Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease , 2017, Medicine.

[7]  Umbreen Ahmed,et al.  HAEMATOLOGICAL PARAMETERS ALTERED IN TUBERCULOSIS , 2015 .

[8]  Toshio Tanaka,et al.  IL-6 in inflammation, immunity, and disease. , 2014, Cold Spring Harbor perspectives in biology.

[9]  D. Kaushal,et al.  Role of interleukin 6 in innate immunity to Mycobacterium tuberculosis infection. , 2013, The Journal of infectious diseases.

[10]  Y. Cavalcanti,et al.  Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis , 2012, Pulmonary medicine.

[11]  F. Şahin,et al.  Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis , 2012, Multidisciplinary Respiratory Medicine.

[12]  P. Akpan,et al.  Some Haematological Parameters of Tuberculosis (TB) Infected Africans: The Nigerian Perspective , 2012 .

[13]  S. Margetić.  Inflammation and haemostasis , 2012, Biochemia medica.

[14]  V. Toledo,et al.  Evaluation of the Immune Response of Individuals Infected with Mycobacterium tuberculosis and Patients with Active Tuberculosis , 2012 .

[15]  M. Schmelzle,et al.  Making sense of regulatory T cell suppressive function. , 2011, Seminars in immunology.

[16]  Yong-hong Feng,et al.  Elevated Serum Levels of CCL17 Correlate with Increased Peripheral Blood Platelet Count in Patients with Active Tuberculosis in China , 2011, Clinical and Vaccine Immunology.

[17]  C. Sano,et al.  Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[18]  E. Favaloro,et al.  Quality in coagulation and haemostasis testing , 2010 .

[19]  J. Ramirez,et al.  Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. , 2010, Chest.

[20]  P. Verhamme,et al.  Hemostasis and inflammation: two of a kind? , 2009, Thrombosis journal.

[21]  D. Stafforini,et al.  The emerging roles of PAF acetylhydrolase This work was supported by National Institutes of Health Grants HL44513, HL35828, and HL087018. Published, JLR Papers in Press, October 6, 2008. , 2009, Journal of Lipid Research.

[22]  R. Reljic,et al.  TNF-α in Tuberculosis: A Cytokine with a Split Personality , 2009 .

[23]  A. Abbas,et al.  Interleukin‐2 in the development and control of inflammatory disease , 2008, Immunological reviews.

[24]  S. Girardin,et al.  Chronic inflammation: importance of NOD2 and NALP3 in interleukin‐1β generation , 2006 .

[25]  K. Kaushansky,et al.  Lineage-specific hematopoietic growth factors. , 2006, The New England journal of medicine.

[26]  H. Hamm,et al.  Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP. , 2006, Blood.

[27]  J. Keane.  TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. , 2005, Rheumatology.

[28]  J. Morgan,et al.  Physical mapping of the CXC chemokine locus on human chromosome 4 , 1999, Cytogenetic and Genome Research.

[29]  Ş. Kirazlı,et al.  In vivo platelet and T-lymphocyte activities during pulmonary tuberculosis. , 1998, The European respiratory journal.

[30]  P. Akpan,et al.  The role of cytokines in fibrinolysis: A case study of active tuberculosis. , 2017 .

[31]  B. Shrestha,et al.  OCCURRENCE OF SIDE EFFECTS FROM ANTI-TUBERCULOSIS DRUGS IN URBAN NEPALESE POPULATION UNDER DOTS TREATMENT , 2005 .

[32]  S. Shattil.  Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. , 1999, Thrombosis and haemostasis.

[33]  Hee-Joo Lee,et al.  Mean Platelet Volume in Mycobacterium tuberculosis Infection , 2016, BioMed research international.